Pluri Inc. Foreign Currency Transaction Gain (Loss), before Tax
Pluri Inc. (PLUR) reported Foreign Currency Transaction Gain (Loss), before Tax of -$278.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-09-10
- Pluri Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$404.00K.
- Pluri Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $483.00K.
- Pluri Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$314.00K, a 117.90% decline year-over-year.
- Pluri Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$43.00K.
- Pluri Inc. foreign currency transaction gain (loss), before tax for fiscal 2026 was -$278.00K.
- Pluri Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$2.16M, a 1811.90% decline from fiscal 2024.
- Pluri Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was $126.00K.
- Pluri Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$1.71M, a 285.36% decline from fiscal 2022.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $79.00K derived: sum of 2 quarters · filed 2026-09-10 | -$235.00K derived: sum of 3 quarters · filed 2026-09-10 | -$278.00K 10-K · filed 2026-09-10 | |
| 2026-03-31 | $483.00K 10-Q · filed 2026-05-14 | $169.00K derived: sum of 2 quarters · filed 2026-05-14 | $126.00K 10-Q · filed 2026-05-14 | -$1.85M derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-12-31 | -$314.00K 10-Q · filed 2026-02-12 | -$357.00K 10-Q · filed 2026-02-12 | -$2.33M derived: sum of 3 quarters · filed 2026-09-10 | -$3.28M derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-09-30 | -$43.00K 10-Q · filed 2025-11-12 | -$2.02M derived: sum of 2 quarters · filed 2026-09-10 | -$2.96M derived: sum of 3 quarters · filed 2026-09-10 | -$1.21M derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-06-30 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | -$2.92M derived: sum of 2 quarters · filed 2026-09-10 | -$1.17M derived: sum of 3 quarters · filed 2026-09-10 | -$2.16M 10-K · filed 2026-09-10 | |
| 2025-03-31 | -$945.00K 10-Q · filed 2026-05-14 | $809.00K derived: sum of 2 quarters · filed 2026-05-14 | -$183.00K 10-Q · filed 2026-05-14 | -$116.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $1.75M 10-Q · filed 2026-02-12 | $762.00K 10-Q · filed 2026-02-12 | $829.00K derived: sum of 3 quarters · filed 2026-02-12 | $956.00K derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-09-30 | -$992.00K 10-Q · filed 2025-11-12 | -$925.00K derived: sum of 2 quarters · filed 2025-11-12 | -$798.00K derived: sum of 3 quarters · filed 2025-11-12 | -$926.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | $194.00K derived: sum of 2 quarters · filed 2025-09-17 | $66.00K derived: sum of 3 quarters · filed 2025-09-17 | $126.00K 10-K · filed 2025-09-17 | |
| 2024-03-31 | $127.00K 10-Q · filed 2025-05-13 | -$1.00K derived: sum of 2 quarters · filed 2025-05-13 | $59.00K 10-Q · filed 2025-05-13 | ||
| 2023-12-31 | -$128.00K 10-Q · filed 2025-02-11 | -$68.00K 10-Q · filed 2025-02-11 | |||
| 2023-09-30 | $60.00K 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | -$1.71M 10-K · filed 2024-09-18 | ||||
| 2022-06-30 | $922.00K 10-K · filed 2023-09-12 | ||||
| 2021-06-30 | $332.00K 10-K · filed 2022-09-21 | ||||
| 2020-06-30 | -$41.00K 10-K · filed 2021-09-13 | -$155.00K 10-K · filed 2020-09-10 | |||
| 2019-06-30 | $26.00K 10-K · filed 2020-09-10 | -$26.00K 10-K · filed 2019-09-12 | |||
| 2018-06-30 | -$52.00K 10-K · filed 2020-09-10 | $52.00K 10-K · filed 2018-09-12 | |||
| 2017-06-30 | $182.00K 10-K · filed 2019-09-12 | ||||
| 2016-06-30 | -$174.00K 10-K · filed 2018-09-12 | ||||
| 2015-06-30 | -$1.11M 10-K · filed 2017-09-07 | ||||
| 2014-06-30 | $407.00K 10-K · filed 2016-09-07 | ||||
| 2013-06-30 | $497.00K 10-K · filed 2015-09-09 | ||||
| 2012-06-30 | -$98.00K 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |